Wang, Gui-Zhen

Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents. [electronic resource] - Cancer science Jul 2015 - 902-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1349-7006

10.1111/cas.12679 doi


Antineoplastic Agents--pharmacology
Cell Line, Tumor
Cisplatin--pharmacology
Drug Synergism
Fanconi Anemia Complementation Group D2 Protein--metabolism
Humans
Lung Neoplasms
Pentacyclic Triterpenes
Proteasome Endopeptidase Complex--metabolism
Protein Stability
Proteolysis
Triterpenes--pharmacology